← FDA Drug Approvals (Drugs@FDA)

METHOCARBAMOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2017-07-18

Drug application

FDA Application #

ANDA205404

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHOCARBAMOL

Generic name

METHOCARBAMOL

Active ingredients

METHOCARBAMOL

Dosage form

SOLUTION

Route

IM-IV

Marketing status

Prescription

Sponsor

SAGENT PHARMS INC

Manufacturer

Sagent Pharmaceuticals

First approval

2017-07-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown